ALS Learning Series
Evidence-Based Consensus Guidelines for Genetic Counseling and Testing in ALS
May 11, 2023
Jennifer Roggenbuck, MS, CGC
The practice of genetic testing in ALS has been impacted by high patient demand for testing, sponsored testing programs, and a new drug application to the FDA for the first gene-targeted therapy in ALS. However, many challenges exist, including few genetic counselors in ALS clinics, and issues with laboratory methods and reporting. Jennifer Roggenbuck, MS, CGC will present new evidence-based, consensus guidelines for genetic counseling and testing in ALS, a project sponsored by the ALS Association.
Jennifer Roggenbuck is a genetic counselor and Associate Professor at the Ohio State University, where she studies genetic testing and counseling outcomes and best practices in ALS clinical genetics.